Table 2.
Aortic gene expression
| Untreated | Treated | Untreated | Treated | |
|---|---|---|---|---|
| NFD-fed | NFD-fed | HFD-fed | HFD-fed | |
| F4/80 | 0.95 ± 0.07 | 0.54 ± 0.08 | 5.65 ± 0.28* | 0.57 ± 0.14‡ |
| CXCR3 | 1.25 ± 0.07 | 1.10 ± 0.01 | 2.55 ± 0.07* | 1.40 ± 0.01*‡ |
| VCAM-1 | 2.40 ± 0.57 | 2.28 ± 0.04 | 6.10 ± 0.14* | 3.65 ± 0.21*‡ |
| CCL2 | 1.05 ± 0.07 | 1.05 ± 0.07 | 1.78 ± 0.04* | 1.05 ± 0.07‡ |
| TNF-α | 1.10 ± 0.01 | 1.00 ± 0.01 | 1.63 ± 0.04* | 1.10 ± 0.14‡ |
| IFN-γ | 1.40 ± 0.14 | 1.08 ± 0.11 | 4.12 ± 0.26* | 1.92 ± 0.12*‡ |
| IL-1β | 0.32 ± 0.02 | 0.32 ± 0.03 | 0.58 ± 0.01* | 0.27 ± 0.02 |
| IL-4 | 0.48 ± 0.04 | 0.54 ± 0.04 | 0.31 ± 0.02* | 0.44 ± 0.04†‡ |
| IL-10 | 0.12 ± 0.02 | 0.13 ± 0.02 | 0.14 ± 0.04 | 0.19 ± 0.01†§ |
| MMP-2 | 0.79 ± 0.04 | 0.80 ± 0.03 | 0.83 ± 0.03 | 0.75 ± 0.07 |
| MMP-9 | 1.01 ± 0.04 | 0.96 ± 0.05 | 2.29 ± 0.09* | 1.43 ± 0.06*‡ |
| CHOP | 2.88 ± 0.16 | 2.75 ± 0.13 | 3.72 ± 0.10* | 3.13 ± 0.06†‡ |
| Annexin | 0.58 ± 0.11 | 0.58 ± 0.03 | 0.84 ± 0.02† | 1.02 ± 0.05*§ |
| TG-2 | 0.62 ± 0.02 | 0.64 ± 0.06 | 0.63 ± 0.04 | 0.66 ± 0.04 |
| MGFE8 | 0.46 ± 0.03 | 0.46 ± 0.01 | 0.55 ± 0.03 | 0.51 ± 0.02 |
| CD36 | 1.96 ± 0.07 | 1.96 ± 0.05 | 7.47 ± 0.15* | 2.08 ± 0.10‡ |
| TLR-2 | 0.73 ± 0.06 | 0.73 ± 0.07 | 1.04 ± 0.05* | 0.79 ± 0.04‡ |
| TLR-4 | 0.64 ± 0.04 | 0.58 ± 0.08 | 0.78 ± 0.03* | 0.52 ± 0.03‡ |
| RAGE | 1.18 ± 0.04 | 1.16 ± 0.03 | 2.05 ± 0.07* | 1.50 ± 0.01*‡ |
| Galectin-3 | 1.19 ± 0.01 | 1.19 ± 0.04 | 5.53 ± 0.25* | 1.58 ± 0.08†‡ |
*P < 0.001 or †P < 0.01 versus NFD-fed mice; ‡P < 0.001 or §P < 0.05 versus untreated mice.
Comparison of untreated and D-carnosine octylester-treated ApoE null mice fed a NFD or a HFD.